ResearcherChinese PLA General HospitalNo recent work listed
Hailiang Liu
Matched on ORCID iD 0000-0002-5521-3746; OpenAlex author ID A5100713575. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.817747↗
- Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.01378↗
- Clinical Significance of Preoperative CD8+ Central Memory T Cells for Operable Pancreatic Adenocarcinoma. Co-author DOI 10.1159/000440681↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rong Liu · 3 shared papers, 2015–2021 · strength 0.41
- Paper Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal… DOI 10.3389/fonc.2021.817747↗
- Paper Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcino… DOI 10.3389/fonc.2020.01378↗
- Paper Clinical Significance of Preoperative CD8+ Central Memory T Cells for Operable Pancreatic Adenocarcinoma. DOI 10.1159/000440681↗
- Minggen Hu · 1 shared paper, 2015 · strength 0.06
- Zhiming Zhao · 1 shared paper, 2015 · strength 0.06
- Yongjie Wu · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.